Abstract
The invention provides a recombinant probiotic gram-negative bacterium engineered to grow on a rare carbohydrate as sole carbon source, and whose ability to colonize the mammalian gut is responsive to the supply of said carbohydrate. The invention further provides a pharmaceutical composition or kit comprising the recombinant probiotic gram-negative bacterium and said carbohydrate.
Original language | English |
---|---|
IPC | C12P 21/ 02 A I |
Patent number | WO2022013269 |
Filing date | 15/07/2020 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 15/07/2020 |
Priority number | EP20200186080 |
Publication status | Published - 20 Jan 2022 |